Board of Visitors

Minnie V. Baylor-Henry, JD

Minnie V. Baylor-Henry

• Minnie V. Baylor-Henry received her pharmacy degree from Howard University’s College of Pharmacy and a law degree from Catholic University’s Columbus School of Law. A retired pharmacist, she is a member of the HU College of Pharmacy Board of Visitors and is a member of the Howard University Board of Trustees.

• She is the President of B-Henry & Associates, a consulting firm that provides regulatory expertise to pharmaceutical & medical devices companies.

• She is the former Worldwide Vice President for Regulatory Affairs, Johnson & Johnson (J&J) Medical Devices & Diagnostics. In this capacity, she was responsible for coordinating the regulatory strategy for J&J’s global medical devices’ companies.

• She served previously as the Vice President for Global Regulatory Affairs OTC at McNeil Consumer & Specialty Pharmaceuticals, a J&J company; and Senior Director of Regulatory Affairs at J&J’s Pharmaceutical Research & Development Company. Previously, Ms. Baylor-Henry also served as a Consultant in the Life Sciences Regulatory Practice at Deloitte & Touche LLP. She began her Regulatory Affairs career at the US Food & Drug Administration where she was the Director of the Division of Drug Marketing, Advertising, and Communications and as FDA’s National Health Fraud Coordinator.

• She is the Past President & Chair of the Board of the Drug Information Association and Chair of the Board of the Food and Drug Law Institute.

• Currently, Ms. Baylor-Henry is an Independent Director for several public companies, as well as a Board Director for many non-profit organizations.


Minnie V. Baylor-Henry, JD

Board of Trustees, Howard University

Board of Visitor, Chair

President, Baylor-Henry Associates, Boston, MA

Leonard Edloe, PharmD, RPh


• Leonard Edloe, RPh, PharmD, Pharmacist Edloe earned pharmacy degrees at Howard University and the University of Florida and a divinity degree from Virginia Union University. He also received a degree in theology from Union PresbyterianSeminary.

• He is a retired CEO and pharmacist at Edloe’s Professional Pharmacies in Richmond, Virginia and is the Pastor of New Hope Fellowshipin Hartfield,Virginia.

• He has served as a preceptor at Howard University where he is Vice-Chair of the Board of Visitors of the College of Pharmacy, HamptonUniversity, VirginiaCommonwealthUniversity,and the Universityof South Carolina.

• Pharmacist Edloe became involved in APhA as a student. He served as Chapter President, Regional President and the student representativeto the APhA House of Delegates.

• After graduating from pharmacy school, he served on the Task Force on Women in Pharmacy, the APhA Board of Trustees, and the APhAFoundationBoard.

• Pharmacist Edloe has chaired numerous boards on a local, state, and regional level. Democratic and Republican governorshaveappointedhim to boards and commissionsto servethe citizensof the Commonwealthof Virginia.

• In addition to making numerous presentations on health to community groups, Dr. Edloe hosted a call-in radio show about healthinformationand how pharmacycan improvehealthcarein the UnitedStates.

• He receivedthe ChaunceyI. Cooper Medaland Virginia'sOutstandingPharmacistAward.

• He isa fellowof both APhA and NPhA. and servedas Presidentofthe APhA Foundation

• Dr. Edloe is the recipient of numerous awards including the Bowl of Hygeia, the Terrence Burroughs Leadership Award, the VirginiaRetailerof the Year Award,and the APhA Hugo H. SchaeferAward.

Leonard Edloe, PharmD, RPh

Co-Chair, Board of Trustee, Howard University College of Pharmacy, Washington DC

Frank Logan Brown Jr. MD FACP, FRSM

• Frank Logan Brown Jr. MD FACP, FRSM MD, received his MBA from Yale University School of Medicine; his BS, Virginia CommonwealthUniversity;Pharmacydegree,HowardUniversityCollegeofPharmacy.

• He is currently a Physician Executive with current licensure in Kentucky, North Carolina, Pennsylvania, and Virginia, his general specialties are Medical Management and Medical Devices with specialty focus in: Patentee, Patents, Inventor, Medical Innovator, Medical Devices, Intellectual Property, Credentialing/Privileging, Peer Review, Healthcare Quality, Physician Performance Management,Value-BasedCare,ClinicalMergers& Acquisitions,DosingErrors,and HealthcareFraud.

• He is a Fellow of the American College of Physicians, the American College of Emergency Physicians, the American College of Clinical Pharmacology,the RoyalSocietyof Medicine,and theAmericanAcademy ofCommunications.

• He also serves as the Senior Medical Correspondent for station WVGB-FM in Beaufort, South Carolina. He was awarded 6 patents in the United States for the design of systems to improve patient health engagement and health system management. In addition to SenateSubcommitteetestimony,wherehe has doneplaintiffanddefenseworkin six stateswithintheUnitedStates.

• As a correspondent, he hosts daily coronavirus updates, weekly interview programs, and periodic Coronavirus Townhall presentations.Withover 35 yearsof experiencein thenationalhealthinsuranceindustry,his areasof expertiseinclude: (1) Value-based care (>10 ACO's managed) (2) Appeals (> 500 including face-to-face customer interviews) (3) Boards of directorship representation (AHA, NMSS, United Way) (4) Clinical Mergers and Acquisitions (Oxford/Oaktree, Anthem/Trigon} (5) Commercial acting representing Cigna (ATL, LA, NY, Philadelphia markets) (6) Executive leadership (CHIE designation, Vice President, Sr. Medical Director) (7) Fraud & abuse (>100 cases) (8) Medical necessity review (>50,000 chart reviews) (9) Peer Review (10) Medical innovation (US Inventor; Patentee) (11) Quality management (Malcolm Baldrige, NCQA) (12) Physician credentialing (>20,000 file reviews; >500 hearings) (13) Wellness program implementation (14) Sales (> 300 sales presentations) (15) Executive physician coaching.


Frank Logan Brown Jr. MD FACP, FRSM

Internal Medicine Physician,

Medical Management and Medical Devices, South Carolina

Sybil Richard Green, JD, MHA, RPh


•Sybil Green earned a Bachelor of Science in pharmacy from Xavier University in Louisiana. She received a dual a Juris Doctor and Master of Health Administration, Indiana University. Sybil was the 2000 David A. Winston Health Policy Fellow, and in 2011, she received Certification in Healthcare compliance.

• She is the Director of Coverage and Reimbursement at the American Society of Clinical Oncology in Alexandria, Virginia where she leads efforts to ensure access to and payment for high quality care for cancer patients at all disease stages and trough survivorship.

• In 2015, Sybil took on the role of Adjunct Professor at the George Washington University, where she teaches Introduction to U.S. Health Services Delivery for Master of Public Health Students at the Milken Institute School of Public Health.

• Sybil formerly served as Vice President of Health and Wellness Compliance at Walmart Stores,

• She currently servers on College of Pharmacy Boards of Visitors for Howard University, University of Florida and University of Arkansas for Medical Sciences. Prior to joining Walmart, she was the Deputy Secretary for the Louisiana Department of Health & Hospitals.

• Formerly she served as the Assistant Deputy Secretary for the Florida Agency for Health Care Administration and Director of Policy and Programs for the National Association of Chain Drug Stores.

Sybil Richard Green, JD, MHA, RPh

Director of Coverage and Reimbursement at the American Society of Clinical Oncology in Alexandria, Virginia

Michael Kim, PharmD, RPh

Michael Kim, PharmD, RPh

• Dr. Michael Kim received his PharmD, from Howard University in 1998 and was part of the first ever entry-level PharmD, class to graduate from the College of Pharmacy.

• He is an entrepreneurial pharmacist and currently owns multiple pharmacies in the District of Columbia and Maryland with his pharmacist wife, Joan Kim.

• Dr. Kim has been the recipient of several awards since graduation including the Bowl of Hygeia award, Distinguished Young Pharmacist award, Howard University College of Pharmacy Alumnus of the Year award, and the Washington DC Pharmacy Association Pharmacist of the Year.

• He has been featured in multiple pharmacy publications and has been interviewed by many news media such as CNN, NBC, ABC and NPR.

• Dr. Kim is the current Chairman of the Care Pharmacies Board of Directors, Vice President of NCPA and sits on many other Boards and committees.

• Dr. Kim enjoys serving the diverse communities of DC and advocates to keep independent community pharmacies in our communities as the most accessible healthcare providers.

Michael Kim, PharmD, RPh

Owner and President,

Grubbs Pharmacy,

Washington, D

Emmanuel O Fadiran, RPh, PhD

● Dr. Emmanuel O (“Tayo”) Fadiran, BS Pharmacy and MS from Obafemi Awolowo University, Ile-Ife,Nigeria and a PhD in Pharmaceutical Sciences from the University of Strathclyde, Glasgow, UK. Dr. Fadiran is a recipient of the prestigious Fogarty International Fellowship of the National Institutes of Health (NIH) (1991-1993) as well as numerous awards from the FDA in recognition of his outstanding contributions to regulatory review of applications and development of regulatory guidance’s and policies.

● He is the Senior Vice President of Regulatory Affairs, Anavex Life Sciences Corp. has over 26 years of experience in government service, of which 24 years were dedicated to the US Food and Drug Administration (FDA) During his 24 years, tenure at the FDA he reviewed hundreds of NDAs, sNDAs, BLAs, ANDAs and INDs for approval and strategic recommendations for development of several products across many therapeutic categories. He was also on review teams for several novel therapies including first in class approvals. He also led a cross-disciplinary NDA review team and authored the first Cross-Discipline Team Leader (CDTL) review for the Division of the Pulmonary & Allergy Products, Office of Drug Evaluation II, CDER. He was actively involved in the writing, internal/external training and the implementation of the US FDA Guidance for Industry for population pharmacokinetics. During his tenure as Intramural Research Program Director in the Office of Women’s Health. He was instrumental in advancing women’s health at FDA through selection and funding of several research products with significant regulatory and clinical impacts. In his current role provides regulatory guidance for pharmaceutical product development as well asleadership for all regulatory submissions to FDA and EMA. Heisalso involved in strategic planning for product development and acquisition/licensing as well as in hiring top level management employees.

● Prior he was Professor at Faculty of Pharmacy, College of Medicine, University of Lagos, Lagos, Nigeria for 10 years.

● Prior to Anavex®, Dr. Fadiran served as intramural Research Program Director in the Office of Women’s Health and asa Clinical Pharmacology Team Leader at FDA, Center for Drug Evaluation and Research (CDER). Dr. Fadiran has been involved in the formulation of significant strategic FDA regulatory initiatives including serving as a member of the Senior Management Teams for the Data Standard (Janus) and Sentinel Initiatives. He was an active member of the FDA Senior Science Council working group for the creation and launching of the FDA’s Strategic Plan for Regulatory Science.

● Recently he has played an active role in the development of the Comprehensive in vitro Proarrhythmia Assay (CiPA) for future replacement of the thorough QT studies. As a long-term member of the FDA Institutional Review Board (IRB) he reviewed numerous clinical protocols and actively contributed to the development of standard operating procedures (SOP) for the committee.

● Dr. Fadiran has published extensively in peer-reviewed scientific journals and has made numerous presentations at national and international scientific conferences.

● He is the author/co-author of 4 book chapters, co-editor of one book and a Special issue of Birth Defects Research (Part C) (BDR-C) (Part C), 30 peer-reviewed manuscripts and over 70 presentations at national and international scientific meetings.

Emmanuel O Fadiran, RPh, PhD

Senior Vice President,

Regulatory Affairs Anavex Life Sciences Corp.


Adora Ndu, PharmD, JD

Adora Ndu, PharmD, JD

• Dr. Adora Ndu received her Doctor of Pharmacy degree from Howard University; JD from the University of Maryland, currently she is Vice President, Regulatory Affairs at BioMarin Pharmaceutical, Inc. serving as BioMarin’s global head of regulatory policy, research and intelligence, patient engagement, outcomes research, as well as international regulatory affairs. Adora serves on the Board of Directors for the Alliance for Regenerative Medicine (ARM), as chair for the ARM Regulatory Committee and also as chair for the American Society for Gene and Cell Therapy (ASGCT) Regulatory Affairs Committee. Adora is a member of DIA’s North AmericanAdvisoryBoard as well as DIA’s editorial board for the Global Forum publication.

• Prior to BioMarin, she served in multiple roles at the Food and Drug Administration (FDA), including as Commander in the United States Public Health Service, and Director for FDA’s Division of Medical Policy Development where she led the development of a broad range of FDA guidance’s and regulations. At FDA she also held leadership roles in the Office of Prescription Drug Promotion (OPDP) and was involved in FDA’s pharmacovigilance program. Prior to FDA, Adora completed a PGY-1 residency at Georgetown University Hospital and subsequently worked at Procter & GamblePharmaceuticalsas a medical science liaison.

• She was recognized by the Maryland Daily Record in 2016 as a Leading Woman, and also served as a Howard University College of Pharmacy Reflections of a Decade speaker. She played a critical role in establishing the Howard University/FDA Regulatory Affairs and Policy Fellowship established to provide students with practical experience at FDA, academia, and the pharmaceutical industry.

Adora Ndu, PharmD, JD, 
Executive Director and Head of Global Regulatory Policy, Research, & Engagement (PRE) as well as International Regulatory Affairs at BioMarin Pharmaceutical, Inc.


Belinda Hightower, MBA, Ph.D.

● Belinda Hightower holds a dual Doctorate and Master’s in international business, The Keller Graduate School of Management; Bachelor’s in science from DePaul University.

● She is a Licensed Registered Nurse and former clinical Research Coordinator and Study Monitor.

● She serves as a member of the Board of Directors for the Community Youth Network (CYN) located in Grayslake, Illinois.

● She has served as a member of Pharmaceutical Research Manufacturers of America (PhRMA) in conjunction with U.S. Food and Drug Administration for several years.

● She is currently an Independent Clinical and Quality Consultant with 35 plus years of experience in drug development.

● She holds multiple leadership roles across different functions, as well as provided significant contributions towards the development and marketing of drugs, nutrition and devices.

● Prior to retiring in 2013, she held training, clinical operations and GXP quality positions at Abbott Laboratories (AbbVie), Upjohn, and GH Besselaar.

● She has successfully collaborated with large and small corporations including pharmaceutical, biotech and device corporations. She has worked in alignment with numerous therapeutic areas, international markets and successfully served in the capacity of inspection Administration for numerous regulatory inspections conducted by national and international authorities.

● She has served as a member of Pharmaceutical Research Manufacturers of America (PhRMA) in conjunction with U.S. Food and Drug Administration for several years.

Belinda Hightower-Jervis, MBA, Ph.D.

Independent Pharmaceutical Consultant

Ralonda Jasper, MBA

Ralonda Jasper, MBA

• Ralonda Jasper received a B.S. in Consumer Science from Howard University; Master of Business Administration from Saint Louis University. She received the St. Louis Business Journal 40 under 40 Award & the Howard UniversityAlumni Volunteer of the Year Award, both in 2009.

• She completed the Focus St. Louis- Leadership St. Louis program (2010) and the St. Louis Business DiversityInitiativeFellowprogram (2013).

• She currently works for EquifaxWorkforceSolutionsas a strategic business consultant.

• She serves on several non-profit boards including Beyond Housing, the Scholarship Foundation of St. Louis and as board emeritus of The Professional Organization of Women, Inc. Her community mission aligns with one of her favorite quotes "we have been blessed to bless others".

• She has over 20 years of experience in sales and account management with companies such as Dun & Bradstreet, Citigroup and most recently Express Scripts.

• She also serves as the fundraising chair of the Howard University Alumni-St. Louis club in which over $100k has been raised under her leadership. She is an active member of the National Black MBA Association, Delta SigmaTheta Sorority, Inc. and her church, Lane TabernacleCME.

• Her hobbies include volunteering, mentoring, networking, traveling, and exercising.

Ralonda Jasper, MBA 
National Account Executive at Equifax Workforce Solutions

Mark Shaefer, PharmD, FCCP

● Mark has over twenty-five years of HIV & antiviral pharmaceutical experience. He was one of the earliest members of ViiV Healthcare and helped guide the formation of the company. His intensive pharmaceutical experience is complemented by expertise in clinical pharmacy, academic teaching, and research. Following the arc of his career, it’s easy to appreciate Marx's dedication to ensuring access to innovative HIV medicines.

● He earned his PharmD in 1985, University of California at San Francisco; B.S. in Biology from University of California at San Diego & a ClinicalPharmacyResidency at the University of Nebraska Medical Center

● Mark has held academic appointments as Assistant and Associate Professor at the University of Nebraska, is widely published with more than 70 peer-reviewed publications and is valued as a reviewer for multiple journals.

● Mark’s pharmaceutical career in HIV and anti-viral research follows a path of progressive responsibilities from Burroughs Wellcome, he worked on acyclovir & valaciclovir to Glaxo Wellcome, oversaw HIV clinical trials, and to GSK, his expertise for the next nine years which to senior roles, GroupDirector & acting Vice President.

● At GSK, he facilitated merger integration activities, as Acting Vice President, he led the US HIV program, co-chaired the US CommercialStrategy team, & represented HIV interests on the North American medical Executive team.

● He joined ViiV Healthcare in 2009, he was one of ViiV’s three Medical Affairs Heads. After five years, he progressed to a Global Medical Lead for Cabotegravir, a long acting injectable drug for treatment and prevention of HIV.

● Mark lives with wife, Kristy, in Apex, NC, where they raised three children who are now successfully pursuing their own careers. As “empty-nesters”, Mark and Kristy are enjoying greater time and freedom to travel and participate in local events, including concerts, theater productions, Durham Bulls baseball games, and NC State football. Active in cycling and weightlifting,Mark enjoys helping Kristy with her sports photography business.

Mark Shaefer, PharmD, FCCP

Vaiyapuri Subramaniam, PharmD, MS, FCP, FASHP, FASCP,FFIP


• Dr. Vaiyapuri Subramaniam received his Pharm.D. from the University of Arkansas for Medical Sciences College of Pharmacy; B.S. in Pharmacy from the Ohio Northern University College of Pharmacy. He received his M.S. from the National Louis University College of Management and Business and his B.A. from Ohio Wesleyan University. He completed the Executive Management Program for Pharmacy Leaders from the Wharton School, University of Pennsylvania; and a Leadership Fellowship from the Excellence in Government Leadership FellowsProgram.

• He is currently the President of the Washington Metropolitan Society of Health-System Pharmacists (WMSHP), Dr. Subramaniam provides leadership and strategic management for WMSHP which is a professional pharmacy organization consisting of pharmacists in government and multidisciplinary areas of practice from health systems, ambulatory care, academia, community and industry.

• Former pharmacist executive in the US Veterans Health Administration (VHA), he provided programmatic leadership for more than 7000 pharmacists in the VHA health system medical facilities on pharmacy practice policy and provided subject matter expertise on pharmaceutical compliance with sterile compounding, hazardous drugs management and Joint Commission accreditation standards. He was the principal architect on the development of the VHA web-based Adverse Drug Event Reporting Systems that met multi-user expectations for implementation at VHA health systems and pharmacy services. He served as the official representative for VHA to the USP Convention on pharmaceutical practice and compendial standards.

• He served at the US Food and Drug Administration (FDA) as a pharmaceutical scientist and regulatory compliance officer in generic-drug programs, post-marketing drug quality and surveillance, adverse drug reporting regulations and in the development of pharmaceutical compounding regulations. At the FDA, he was appointed by the US surgeon general to a six-year term to the HHSPharmacists Professional Advisory Committee.

• He served extensively in university and teaching hospitals as clinical teaching coordinator, director of pharmacy services and as clinical affiliate professor of pharmacy in experiential education for pharmacy students. He contributes frequently as a speaker at domestic and international venues and coordinates pharmacist continuing education programs. He has published on topics in public health, medication adherence, healthcare disparities, cultural competency, traditional medicines, post-marketing adverse drug reporting, drug quality and USP pharmaceutical compounding practice standards.

• He is the principal author of a book chapter on the Department of Veterans Affairs Pharmacy Programs in the 2016 publication on “Pharmaceutical Public Policy.” In community and volunteer professional service, he was a NIOSH panel reviewer on Hazardous Drugs classifications; member in the USP Nomenclature Advisory Group and USP Special Panel on Pharmaceutical Sterile Compounding Standards; and President of the VHA/VA Chapter of Federal Asian Pacific American Council. He is currently Treasurer and Executive Board Member, Social.

Vaiyapuri Subramaniam, PharmD, MS, FCP, FASHP, FASCP, FFIP
President & Chair Executive Board of Directors, Washington Metropolitan Society of Health System Pharmacists
Former Pharmacist Executive, US Veterans Health Administration; Former Pharmaceutical Scientist & Compliance Officer, US Food and Drug Administration; Former Adjunct Clinical Associate Professor of Pharmacy Practice